Published in Dtsch Med Wochenschr on December 12, 1986
Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab (2001) 6.12
Impairment of antipyrine clearance in humans by propranolol. Circulation (1978) 2.18
Acute health effects of exposure to high levels of air pollution in eastern Europe. Am J Epidemiol (1996) 1.56
Response to methimazole in Graves' disease. The European Multicenter Study Group. Clin Endocrinol (Oxf) (1995) 1.44
Analysis of lorazepam and its glucuronide metabolite by electron-capture gas--liquid chromatography. Use in pharmacokinetic studies of lorazepam. J Chromatogr (1978) 1.41
Clinical usefulness of a new chemiluminescent two-site immunoassay for human calcitonin. Exp Clin Endocrinol Diabetes (1998) 1.40
Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans. J Pharm Sci (1979) 1.37
Absorption and disposition of chlordiazepoxide in young and elderly male volunteers. J Clin Pharmacol (1978) 1.33
A study of complaints and their relation to vertebral destruction in patients with osteoporosis. Bone Miner (1990) 1.30
The natural course of multiple endocrine neoplasia type IIb. A study of 18 cases. Arch Intern Med (1992) 1.29
Histones: genetic diversity and tissue-specific gene expression. Histochem Cell Biol (1997) 1.25
Prognostic value of codon 918 (ATG-->ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma. Int J Cancer (2001) 1.20
A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab (1998) 1.16
Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors. J Nucl Med (1999) 1.13
Influence of magnesium and aluminum hydroxide mixture on chlordiazepoxide absorption. Clin Pharmacol Ther (1976) 1.13
Targeting of cholecystokinin-B/gastrin receptors in vivo: preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabelled gastrin. Eur J Nucl Med (1998) 1.12
Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma. Genes Chromosomes Cancer (1995) 1.10
Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype. Eur J Endocrinol (2006) 1.08
Biomarkers of exposure to passive smoking of school children: frequency and determinants. Indoor Air (2005) 1.07
Intercellular junctions in the vascular stria and spiral ligament. J Ultrastruct Res (1975) 1.05
Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation. Oncogene (1999) 1.03
Effect of propranolol on pharmacokinetics and acute electrocardiographic changes following intravenous quinidine in humans. Pharmacology (1978) 1.02
Expression of a calcium-sensing receptor in a human medullary thyroid carcinoma cell line and its contribution to calcitonin secretion. Endocrinology (1996) 1.02
From genes to proteins: high-throughput expression and purification of the human proteome. J Cell Biochem (2000) 1.00
Diagnosis and management of pheochromocytomas in patients with multiple endocrine neoplasia type 2-relevance of specific mutations in the RET proto-oncogene. Eur J Endocrinol (1996) 0.99
Microsurgical neck dissection for occultly metastasizing medullary thyroid carcinoma. Three-year results. Cancer (1993) 0.97
Absorption rate, blood concentrations, and early response to oral chlordiazepoxide. Am J Psychiatry (1977) 0.97
Maternal and paternal family history of diabetes in women with gestational diabetes or insulin-dependent diabetes mellitus type I. Gynecol Obstet Invest (2001) 0.97
Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration. J Pharmacol Exp Ther (1977) 0.97
Combination chemotherapy of advanced medullary and differentiated thyroid cancer. Phase II study. J Cancer Res Clin Oncol (1990) 0.96
Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy. J Clin Endocrinol Metab (1993) 0.95
The hypercalcaemic syndrome in rats bearing the Walker carcinosarcoma 256. Acta Endocrinol (Copenh) (1975) 0.95
Mutation of the RET proto-oncogene is correlated with RET immunostaining in subpopulations of cells in sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab (1998) 0.95
Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization. Thyroid (1992) 0.95
Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation. Exp Clin Endocrinol Diabetes (2004) 0.94
Transcriptional repression by COUP-TF II is dependent on the C-terminal domain and involves the N-CoR variant, RIP13delta1. J Steroid Biochem Mol Biol (1998) 0.93
Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma. Clin Endocrinol (Oxf) (1995) 0.92
Increased prevalence of colonic adenomas in patients with acromegaly. Eur J Endocrinol (1994) 0.92
Spermatogenesis in mice is not affected by histone H1.1 deficiency. Exp Cell Res (2000) 0.92
Heterogeneous mutation of the RET proto-oncogene in subpopulations of medullary thyroid carcinoma. Cancer Res (1996) 0.92
[Interdisciplinary AWMF guideline for the diagnostics of primary immunodeficiency]. Klin Padiatr (2011) 0.91
Clinical experience in 130 cruciate ligament reconstructions. Orthop Clin North Am (1976) 0.90
Plasma and cerebrospinal fluid concentrations of chlordiazepoxide and its metabolites in surgical patients. Clin Pharmacol Ther (1976) 0.89
Intercellular junctions in the organ of Corti as revealed by freeze fracturing. Acta Otolaryngol (1976) 0.89
Expression of cathepsin K in the human embryo and fetus. Dev Dyn (1999) 0.88
Kinetics of intravenous chlordiazepoxide: sex differences in drug distribution. Clin Pharmacol Ther (1977) 0.88
Synthesis and localization of the mucin-associated TFF-peptides in the human uterus. Cell Tissue Res (2001) 0.88
Somatostatin receptor imaging in persistent medullary thyroid carcinoma. Clin Endocrinol (Oxf) (1995) 0.87
Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group. J Clin Endocrinol Metab (1996) 0.87
Parathyroid hormone-related protein and life expectancy in hypercalcemic cancer patients. J Clin Endocrinol Metab (1994) 0.87
Bioavailability of iodine from normal diets rich in dairy products--results of balance studies in women. Exp Clin Endocrinol Diabetes (2001) 0.87
[Intervertebral disk calcification following fracture of the cervical spine in athletic injury]. Hefte Unfallheilkd (1971) 0.87
Structural parameters affecting the kinetics of RNA hairpin formation. Nucleic Acids Res (2006) 0.86
[Acupuncture massage vs Swedish massage and individual exercise vs group exercise in low back pain sufferers--a randomized controlled clinical trial in a 2 x 2 factorial design]. Forsch Komplementarmed Klass Naturheilkd (2000) 0.86
Chromogranin A as tumor marker in medullary thyroid carcinoma. Thyroid (1992) 0.86
External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys (1995) 0.85
Changing concepts in the management of hereditary and sporadic medullary thyroid carcinoma. Endocrinol Metab Clin North Am (1990) 0.85
Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential. Clin Cancer Res (1999) 0.85
Major role of dihydropyridine-sensitive Ca2+ channels in Ca(2+)-induced calcitonin secretion. Am J Physiol (1993) 0.84
Synaptophysin identified in metastases of neuroendocrine tumors by immunocytochemistry and immunoblotting. Am J Clin Pathol (1987) 0.84
Papillary carcinoma in an ectopic thyroid. Horm Res (1991) 0.84
[Interdisciplinary AWMF guideline for the treatment of primary antibody deficiencies]. Klin Padiatr (2012) 0.84
Are commonly recommended dosages for vitamin D supplementation too low? Vitamin D status and effects of supplementation on serum 25-hydroxyvitamin D levels--an observational study during clinical practice conditions. Osteoporos Int (2010) 0.83
Presymptomatic DNA screening in families with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma. Surgery (1995) 0.83
Isolation of two murine H1 histone genes and chromosomal mapping of the H1 gene complement. Mamm Genome (1995) 0.83
Mutational analysis of the PHEX gene: novel point mutations and detection of large deletions by MLPA in patients with X-linked hypophosphatemic rickets. Calcif Tissue Int (2009) 0.83
Parathyroid hormone-related peptide and 8701-BC breast cancer cell growth and invasion in vitro: evidence for growth-inhibiting and invasion-promoting effects. Mol Cell Endocrinol (1995) 0.83
Maternal compliance with nutritional recommendations in an allergy preventive programme. Arch Dis Child (2002) 0.83
Isoquinolone and protoberberine alkaloids from Stephania rotunda. Pharmazie (2005) 0.83
Absorption of oral and intramuscular chlordiazepoxide. Eur J Clin Pharmacol (1978) 0.82
The use of octreotide in the treatment of medullary thyroid carcinoma. Horm Metab Res Suppl (1993) 0.82
Clinical significance of antibodies against calcitonin. Exp Clin Endocrinol Diabetes (1995) 0.82
Does selection on increased cold tolerance in the adult stage confer resistance throughout development? J Evol Biol (2012) 0.81
Factors influencing blood concentrations of chlordiazepoxide: a use of multiple regression analysis. Psychopharmacology (Berl) (1977) 0.81
New operative strategy in the treatment of metastasizing medullary carcinoma of the thyroid. Eur J Surg Oncol (1990) 0.81
Automatic control and directed cell movement. Novel approach for understanding chemotaxis, galvanotaxis, galvanotropism. Z Naturforsch C (1991) 0.81
Histone gene expression and chromatin structure during spermatogenesis. Adv Exp Med Biol (1997) 0.81
Developing effective screening strategies in multiple endocrine neoplasia type 1 (MEN 1) on the basis of clinical and sequencing data of German patients with MEN 1. Exp Clin Endocrinol Diabetes (2007) 0.80
Histochemical localization of acetylcholinesterase activity in the cochlear and vestibular ganglion cells. Acta Otolaryngol (1974) 0.80
Down-regulation of calcitonin receptors in T47D cells by internalization of calcitonin-receptor complexes. Mol Cell Endocrinol (1988) 0.80
[Hereditary medullary thyroid carcinoma--genotype-phenotype characterization]. Dtsch Med Wochenschr (2003) 0.80
Regulation of calcitonin gene expression by hypocalcemia, hypercalcemia, and vitamin D in the rat. J Bone Miner Res (1992) 0.80
Cyclic AMP formation in rat bone and kidney cells is stimulated equally by parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34. Exp Clin Endocrinol (1993) 0.80
Results and follow-up in eleven MEN 2A gene carriers after prophylactic thyroidectomy. Exp Clin Endocrinol Diabetes (1997) 0.80
Superior local tolerability of human versus salmon calcitonin preparations in young healthy volunteers. Eur J Clin Pharmacol (1991) 0.79
Somatostatin inhibits the norepinephrine-activated calcium channels in rMTC 6-23 cells: possible involvement of a pertussis toxin-sensitive G-protein. Acta Endocrinol (Copenh) (1992) 0.79
Reversible diminished calcitonin secretion in the rat during chronic hypercalcemia. Endocrinology (1984) 0.79
Microsurgical neck dissection for metastasizing medullary thyroid carcinoma. Eur J Surg Oncol (1995) 0.79
Prophylactic thyroidectomy in MEN IIA: does the calcitonin level correlate with tumor spread? Langenbecks Arch Surg (1998) 0.79
Thawing of fresh-frozen plasma with a new microwave oven. Transfusion (1988) 0.79
[Secondary osteoporosis - relevant clinical characteristics in diagnosis and therapy]. Dtsch Med Wochenschr (2012) 0.78
Levels of parathyroid hormone-related protein (PTHrP) in hypercalcemia of malignancy are not lowered by treatment with the bisphosphonate BM 21.0955. Horm Metab Res (1993) 0.78
Circulating levels of midregional parathyroid hormone-related protein in hypercalcaemia of malignancy. Clin Endocrinol (Oxf) (1992) 0.78
Early nutrition and later blood pressure: effect of maternal diabetes. J Pediatr (2001) 0.78
Inhibition of Ca(2+)-induced calcitonin secretion by somatostatin: roles of voltage dependent Ca2+ channels and G-proteins. Cell Signal (1992) 0.78
Single and multiple dose pharmacokinetics of oral quinidine sulfate and gluconate. Am J Cardiol (1978) 0.78
Freeze-fracture study of the cell junctions in the utricle and saccule. Acta Otolaryngol (1977) 0.78
Somatostatin receptor scintigraphy and magnetic resonance imaging in recurrent medullary thyroid carcinoma: a comparative study. Horm Metab Res Suppl (1993) 0.78